THERAZCREAM

Product NDC: 55628-9155
11-digit product format: 556289155
Labeler code: 55628
Product ID: 55628-9155_60e0a8f6-b6f1-4637-8a28-f090ee2bce9f
Type: HUMAN OTC DRUG
Nonproprietary name: TRICLOSAN
Dosage form: CREAM
Route: TOPICAL
Labeler: Cal Pharma
Application: part333A
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2013-04-17
Marketing end: 0000-00-00
Substance: TRICLOSAN
Active strength: 0 g/100mL
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	55628-9155		D	Discontinued by firm		2026-08-03
excluded package	package	55628-9155	55628-9155-9	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 32 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55628-9155-9	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55628-9155-9	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55628-9155-9	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55628-9155-9	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55628-9155-9	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55628-9155-9	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55628-9155-9	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55628-9155-9	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55628-9155-9	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55628-9155-9	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55628-9155-9	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55628-9155-9	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	55628-9155-9	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	55628-9155-9	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	55628-9155-9	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	55628-9155-9	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55628-9155-9	2024-04-01	C162847	48780-1	d6a99b39-b98d-a426-e053-dadaa90af4c2	87812549-30ab-400d-a0e9-0ec00121d1ca
55628-9155-9	2022-01-28	C162847	48780-1	d6a99b39-b98d-a426-e053-dadaa90af4c2	87812549-30ab-400d-a0e9-0ec00121d1ca

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TRICLOSAN	ACTIVE INGREDIENT	4NM5039Y5X	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
TRICLOSAN	ACTIVE MOIETY	4NM5039Y5X	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
ALKYL (C12-15) BENZOATE	INACTIVE INGREDIENT	A9EJ3J61HQ	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
BENZOIC ACID	INACTIVE INGREDIENT	8SKN0B0MIM	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
CARBOMER 940	INACTIVE INGREDIENT	4Q93RCW27E	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	71DD5V995L	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
CERESIN	INACTIVE INGREDIENT	Q1LS2UJO3A	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
CETETH-20	INACTIVE INGREDIENT	I835H2IHHX	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
DIAZOLIDINYL UREA	INACTIVE INGREDIENT	H5RIZ3MPW4	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
ETHYLHEXYLGLYCERIN	INACTIVE INGREDIENT	147D247K3P	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
GLYCERETH-2 COCOATE	INACTIVE INGREDIENT	JWM00VS7HC	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
GLYCERETH-26	INACTIVE INGREDIENT	NNE56F2N14	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
MAGNESIUM ALUMINUM SILICATE	INACTIVE INGREDIENT	6M3P64V0NC	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
PEG-75 STEARATE	INACTIVE INGREDIENT	OT38R0N74H	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
POLYSORBATE 20	INACTIVE INGREDIENT	7T1F30V5YH	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
SHEA BUTTER	INACTIVE INGREDIENT	K49155WL9Y	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
SODIUM METABISULFITE	INACTIVE INGREDIENT	4VON5FNS3C	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
SORBIC ACID	INACTIVE INGREDIENT	X045WJ989B	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
STEARETH-20	INACTIVE INGREDIENT	L0Q8IK9E08	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
STEARETH-21	INACTIVE INGREDIENT	53J3F32P58	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
STEARYL ALCOHOL	INACTIVE INGREDIENT	2KR89I4H1Y	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
UREA	INACTIVE INGREDIENT	8W8T17847W	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
VITAMIN A PALMITATE	INACTIVE INGREDIENT	1D1K0N0VVC	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	THERAZCREAM (TRICLOSAN) CREAM [CAL PHARMA]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4NM5039Y5X	TRICLOSAN	3380-34-5	TRICLOSAN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
55628-9155-9	55628915509	275 mL in 1 TUBE (55628-9155-9)	275 ml	2013-04-17	0000-00-00	No	No	Current

THERAZCREAM

NDC auxiliary status#

Observed NDC auxiliary status history#

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Packages#

Related DailyMed Labels#